Pharmalive - The Pulse of the Pharmaceutical Industry
NEW!
The Pharma Industry
Today's News Pharma Blog Review Med Ad News R & D Directions Special Reports Information Tools eNewsletters Conferences
Aug 20, 2008
NEW YORK, August 19, 2008 – Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of erectile dysfunction drug tadalafil (Cialis) to relieve associated lower urinary tract symptoms (LUTS), according to a new study published in the October 2008 issue of The Journal of Urology.

KENILWORTH, N.J., August 19, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced today that Asmanex Twisthaler 110 mcg (mometasone furoate inhalation powder) is now available in pharmacies nationwide.

ROCKVILLE, Md., Aug. 18, 2008--Since issuing Information for Healthcare Professionals in October 2007, FDA has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta. Byetta is a medicine given by subcutaneous injection to help treat adults with type 2 diabetes.



CLEVELAND & PITTSBURGH--(BUSINESS WIRE)--Aug 19, 2008 - In 2007, the Pittsburgh Life Sciences Greenhouse (PLSG) and BioEnterprise of Cleveland announced a strategic collaboration to work together in creating a "Biosciences Tech Belt" linking the biosciences assets of the adjacent metro areas.

WORCESTER, Mass.--(BUSINESS WIRE)--Aug 19, 2008 - Advanced Cell Technology, Inc. reported that it is feasible to differentiate and mature human embryonic stem cells (hESCs) into functional oxygen-carrying red blood cells (RBCs) under conditions suitable for scale-up.

CARY, N.C., Aug. 19, 2008 – Demonstrating its commitment to a discipline it pioneered – behavioral science based relationship marketing – MicroMass Communications, Inc. has elevated three members of its behavioral services group to key management positions, paving the way for an expansion of the agency’s behavioral services offerings and broader application of its unique relationship marketing methodologies.

SAN JOSE, Calif., Aug. 19, 2008--In an effort to highlight the distinctive aspects of its peptide manufacturing process, AnaSpec has introduced rules 4 and 5 in its popular “Truth in Peptides” campaign.

VIENNA, Va., August 19, 2008 /PRNewswire/ -- Prematics, Inc. is pleased to announce the addition of Dean M. Panovich to the company's executive management team as vice president of deployment.

HERCULES, Calif., Aug. 19, 2008 – Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced today the availability of a technical note (tech note 5720), which describes a study identifying the optimal conditions for electroporating IMR-32 and SK-N-SH neuroblastoma cell lines with plasmid DNA or siRNA.

DURHAM, N.C., August 19, 2008 /PRNewswire/ -- Addrenex Pharmaceuticals has made three strategic hires this month to further its goal of identifying and developing as many new drug candidates as possible over the next 18 months.

DUBLIN, Ireland--(BUSINESS WIRE)--Aug 19, 2008 - Research and Markets has announced the addition of the "The Top 10 World's Leading Pharmaceutical Companies" report to their offering.

NEW YORK--(BUSINESS WIRE)--Aug 19, 2008 - Coughlin Stoia Geller Rudman & Robbins LLP today announced that a class action has been commenced in the United States District Court for the Southern District of New York by an institutional investor on behalf of purchasers of Inyx Inc. common stock during the period between March 31, 2005 and July 2, 2007.

AZUSA, Calif.--(BUSINESS WIRE)--Aug 19, 2008 - Viral Genetics, Inc., a biotechnology company that discovers and develops immune-based therapies, today unveiled a new theory regarding a potential mechanism of action, which could advance HIV/AIDS research and the development of an inexpensive, effective therapy for HIV.

SPRINGFIELD, IL – Aug. 19, 2008 – H. D. Smith today announced a new agreement with Net-Rx of Vancouver, WA, to provide the Net-Rx Profit Optimizer Service as an additional business tool for existing H. D. Smith customers.

CAMBRIDGE, England, Aug. 19, 2008--Activotec (www.activotec.com) has released a new brochure for its Activo-P11 Peptide Synthesizer that includes description of a host of new technical innovations that further enhance synthesis of very high quality peptides.

 
paid advertisement

paid advertisement
User Tools
Subscriber registration
Purchase a subscription
Forget your password
Need help?
Your account details
Order back issues
Renew subscription
Advertise

Download the Med Ad News, R&D Directions, and PharmaLive.com media kit




ABOUT SSL CERTIFICATES
Med Ad News
R&D Directions
Special Reports
Conferences
©2008 Canon Communications Pharmaceutical Media Group